menu search

OMCL / 4 Toxic Stocks That May Not Let You Prosper

4 Toxic Stocks That May Not Let You Prosper
If you own toxic stocks for long, you are likely to see a big loss in your wealth. Stay away from toxic stocks like BALY, OMCL, AY and TFSL. Read More
Posted: Feb 8 2023, 09:02
Author Name: Zacks Investment Research
Views: 112019

OMCL News  

OMCL vs. PRVA: Which Stock Should Value Investors Buy Now?

By Zacks Investment Research
November 3, 2023

OMCL vs. PRVA: Which Stock Should Value Investors Buy Now?

Investors interested in Medical Info Systems stocks are likely familiar with Omnicell (OMCL) and Privia Health (PRVA). But which of these two companie more_horizontal

Omnicell (OMCL) Q3 Earnings and Revenues Beat, Margins Down

By Zacks Investment Research
November 3, 2023

Omnicell (OMCL) Q3 Earnings and Revenues Beat, Margins Down

Omnicell's (OMCL) third-quarter 2023 results reflect operational discipline in a weak demand environment. more_horizontal

Here's Why Investors Should Retain Omnicell (OMCL) Stock Now

By Zacks Investment Research
September 27, 2023

Here's Why Investors Should Retain Omnicell (OMCL) Stock Now

Investors are optimistic about Omnicell (OMCL), led by its digital transformation strategy. more_horizontal

Omnicell to Present at the 2023 Wells Fargo Healthcare Conference

By Business Wire
August 23, 2023

Omnicell to Present at the 2023 Wells Fargo Healthcare Conference

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Present at the 2023 Wells Fargo Healthcare Conference. more_horizontal

Omnicell Inc: A Healthcare Stock with Good Outperformance Potential

By GuruFocus
August 2, 2023

Omnicell Inc: A Healthcare Stock with Good Outperformance Potential

Omnicell Inc ( OMCL , Financial), a prominent player in the Healthcare Providers & Services industry, is currently trading at $64.36 with a market cap more_horizontal

Omnicell (OMCL) Q2 Earnings and Revenues Top, '23 View Raised

By Zacks Investment Research
August 2, 2023

Omnicell (OMCL) Q2 Earnings and Revenues Top, '23 View Raised

Omnicell's (OMCL) second-quarter 2023 performance reflects strength in advanced services and technical services as well as continued strong execution. more_horizontal

Omnicell, Inc. (OMCL) Q2 2023 Earnings Call Transcript

By Seeking Alpha
August 1, 2023

Omnicell, Inc. (OMCL) Q2 2023 Earnings Call Transcript

Omnicell, Inc. (NASDAQ:OMCL ) Q2 2023 Earnings Conference Call August 1, 2023 4:30 PM ET Company Participants Kathleen Nemeth - Head of IR Randall Lip more_horizontal

Omnicell (OMCL) Surpasses Q2 Earnings and Revenue Estimates

By Zacks Investment Research
August 1, 2023

Omnicell (OMCL) Surpasses Q2 Earnings and Revenue Estimates

Omnicell (OMCL) came out with quarterly earnings of $0.57 per share, beating the Zacks Consensus Estimate of $0.28 per share. This compares to earning more_horizontal


Search within

Pages Search Results: